Skip to main content

Table 2 Demographic and clinical characteristics of study subjects

From: Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia

 

Total

Male

Female

Number of subjects, n (%)

200

129(64.5)

71(35.5)

Age (in years) mean ± SD

38.4 ± 9.8

38.4 ± 10.1

38.4 ± 9.4

Waist circumference in cm mean ± SD

89.3 ± 9.7

88.4 ± 8.7

91 ± 11

BMI (Kg/m2) ≥ 25 n (%)

73(36.5)

32(24.8)

41(57.7)

Ethnicity n (%)

 Amhara

82(41.0)

48(37.2)

34(47.9)

 Oromo

45(22.5)

30(23.3)

15(21.1)

 Tigray

8(4.0)

5(3.9)

3(4.2)

 Gurage

42(21.0)

28(21.7)

14(19.7)

 others

23(11.5)

18(14.0)

5(7.0)

Systolic Blood pressure (mm Hg) mean ± SD

120 ± 18

121 ± 17

118 ± 21

Diastolic Blood Pressure (mm Hg) mean ± SD

78.4 ± 11.5

78.7 ± 11.7

78.0 ± 11.1

Pharmacological treatment n (%)

 FGAs

132(66.3)

88(68.8)

44(62.0)

 SGAs

67(33.7)

40(31.2)

27(38.0)

Lives with parental family n (%)

160(80.0)

112(86.8)

48(67.6)

PANSS Score mean ± SD

83.6 ± 15.4

84.0 ± 15.4

82.9 ± 15.6

Smokers n (%)

42(21.4)

41(32.5)

1(1.4)

Khat chewing Status n (%)

 Yes

16(8.2)

16(12.7)

0(0)

 No

180(91.8)

110(87.3)

70(100)

Occupational Status, working n (%)

44(22.0)

29(22.5)

15(21.1)

Duration of illness (Years), mean ± SD

14 ± 9

15 ± 9

14 ± 9

Marital Status, Married n (%)

28(14.0)

15(11.6)

13(18.3)

Total Cholesterol (mg/dl), median (IQR)

183(216–157)

176(211–154)

198(221–174)

Triglycerides (mg/dl), median (IQR)

118(164–83)

123(179–87)

103(149–77)

HDL-Cholesterol (mg/dl), median (IQR)

45(54–38)

43(49–36)

50(60–44)

FBG(mg/dl), median (IQR)

91(100–86)

91(98–86)

91(103–86)

  1. Abbreviations: COR Crude odds ratios, SD standard deviation, BMI Body mass index, WC Waist Circumference, BP blood pressure, PANSS Positive and Negative Syndrome Scale, FGAs first generation antipsychotics, SGAs second generation antipsychotics, HDL high-density lipoprotein, FBG Fasting blood glucose, IQR interquartile range